Tag Archives: Pfizer

Lost in the Pfizer press release that vaccine is 90% effective: ‘Percentage may vary’

Article content continued “I just want to see the evidence.” Canada has bought the rights to 20 million doses of Pfizer’s vaccine. Ottawa, hedging its bets, has also signed pre-order agreements with Quebec-based Medicago, Moderna and other companies for up to 358 million doses of different vaccine candidates. A federal advisory committee has recommended those… Read More »

Pfizer urged to hold off on coronavirus vaccine until late November: report

Pfizer CEO Albert Bourla and his vaccine partner BioNTech have said the companies expect phase 3 data by the end of October—and that an FDA application could soon follow. But more than 60 researchers and bioethicists urged the partners to wait for more safety data before submitting their shot for a green light, Bloomberg reports. The experts called on… Read More »

ESMO: Pfizer, Merck KGaA’s Bavencio comes up short against placebo in risky head and neck cancer trial

Sometimes in oncology, where both the unmet need and the level of competition are high, when you see a signal, you go for it. Taking on a bit more risk to head into phase 3 can make sense “because the patients are waiting and the business opportunity is in front of you,” as one Pfizer… Read More »